biomedical-data
(5)
DNAnexus makes the lab bigger than the laptop
Sequencing became cheaper. Making sense of the results remained expensive. DNAnexus built a business in that gap, moving biomedical research into shared cloud workspaces - with all the promise, bills and permissions that entails.
Seven Bridges and the Genome That Stayed Put
The clever move in genomics was to stop moving the data. Seven Bridges built a business bringing researchers, workflows and rented computing power to the same place - and now carries that idea into Velsera.
Verily Bet Billions on Health Moonshots. Then It Learned to Clean the Data.
The Alphabet spinout tried smart contact lenses, surgical robots and a watch built for research. After layoffs and a strategic reset, its real product looks less cinematic - and potentially more useful: turning health care’s unruly data into evidence, decisions and care.
Manifold
Manifold is a Boston-area applied-AI company building a vertical agent platform for life sciences. Its software helps pharma companies, molecular diagnostics firms, biobanks and academic medical centers turn messy multimodal biomedical data into governed, analysis-ready insight - compressing workflows that used to take months into minutes, while keeping the data governance that regulated research demands. Founded in 2016 and led by CEO Vinay Seth Mohta, the company raised an $18M Series B in December 2025, bringing total funding to roughly $40M.
Elucidata
Elucidata is a TechBio company building Polly, a data-centric ML-Ops platform that harmonizes messy biomedical data into AI-ready datasets for pharma R&D. Founded in 2015 by Abhishek Jha and Swetabh Pathak, the company powers drug discovery work at Pfizer, Genentech, Janssen and dozens of biotechs from offices in San Francisco, Boston and Delhi.